IP Library Granted Patent US 10,597,650
Granted Patent B2
US 10,597,650 · App. 13/829,489 · Granted Mar 24, 2020

Ligase activity

Inventors: Gregory Lohman (Cambridge, MA); Thomas C. Evans (Topsfield, MA); Larry A. McReynolds (Beverly, MA)
Assignee: New England Biolabs, Inc.
C12N9/93C12N9/00C12Q1/6853C12Q1/6862C12Y605/01003C12Q2521/501C12Q2561/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,597,650
App. No.
13/829,489
Granted
Mar 24, 2020
Kind
B2
Abstract

Compositions and methods are provided for ligating polynucleotides having a length that is greater than 8 nucleotides on an RNA splint. The ligation reaction provides consistent results in high or low ATP concentrations. The reaction can occur rapidly and is generally at least 10 fold more efficient than T4DNA ligase under optimal conditions for T4DNA ligase and the reaction time is less than 6 hours for example, less than 1 hour.

Claims (21)

1. A method for ligating DNA polynucleotide sequences, comprising:

(a) obtaining RNA from a sample that comprises cells or a bodily fluid to produce an RNA sample comprising naturally-occurring RNAs;

(b) hybridizing at least two DNA polynucleotide sequences to a naturally-occurring RNA in the RNA sample;

(c) ligating the at least two DNA polynucleotide sequences to one another using a ligase that has an amino acid sequence that is at least 90% identical to the Chlorella virus PBCV-1 ligase of SEQ ID NO:1: and

(d) detecting the product of step (c).

2. The method of claim 1 , wherein the naturally-occurring RNA is a miRNA, long non-coding RNA, mRNA or tRNA.

3. The method of claim 1 , wherein the ligation of step (c) is a done in a buffer comprising 1 μM to 1.5 mM ATP.

4. The method of claim 1 , wherein the product of step (c) is circular.

5. The method of claim 1 , wherein the product of step (c) is linear.

6. The method of claim 1 , wherein at least 70% of the hybridized oligonucleotides are ligated together within 6 hours.

7. The method of claim 1 , wherein the ligating of step (c) is at least 10 times faster than using T4 DNA ligase with same molar ratio enzyme to substrate an ATP at a concentration of 1 μM to 1.5 mM.

8. The method of claim 1 , wherein the ligase is the Chlorella virus PBCV-1 ligase of SEQ ID NO:1.

9. The method of claim 1 , wherein the method comprises:

(i) hybridizing at least two DNA polynucleotide sequences to the naturally-occurring RNA;

(ii) adding the ligase to the hybridized DNA oligonucleotides; and

(iii) ligating the at least two DNA polynucleotide sequences to one another using the ligase added in (ii).

10. The method of claim 1 , further comprising amplifying the product of step (c).

11. The method of claim 10 , wherein the amplifying is done by PCR.

12. The method of claim 10 , wherein the amplifying is done by rolling circle amplification.

13. The method of claim 1 , wherein the naturally-occurring RNA is complementary to at least 8 nucleotides of each of the at least two DNA polynucleotide sequences.

14. The method of claim 1 , wherein the ligase that has an amino acid sequence that is at least 95% identical to the Chlorella virus PBCV-1 ligase of SEQ ID NO:1.

Assignments (4)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2015
From: MCREYNOLDS, LARRY A.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 036077/0272 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2014
From: MCREYNOLDS, LARRY A.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 033460/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: LOHMAN, GREGORY; EVANS, THOMAS C.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 030212/0474 →